Fig. 3From: Biodistribution, pharmacokinetics, and organ-level dosimetry for 188Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scansNormalized time-activity curves of tumor, liver and lungs for patients that were scanned three times after 188Re-HDD-Lipiodol administrationBack to article page